MustGrow Announces Non-Selective Bio-Herbicide Patent Filing and Supportive Efficacy Claims
27 Janeiro 2020 - 9:00AM
MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF)
(the "
Company", "
MustGrow"), an
agricultural biotech company developing and commercializing a
portfolio of natural, science-based biological crop protection
products, is pleased to announce the filing of patents related to
method-of-use and composition-of-matter claims for a biological
non-selective bio-herbicide, based on MustGrow’s signature
mustard-derived approach to controlling unwanted pests and
diseases.
MustGrow has completed a series of application
rate tests with Canada’s National Research Council to determine the
applicability of MustGrow’s natural mustard-derived technology as a
bio-pesticide. Using multiple application methods, herbicidal
control was achieved after only 72 hours – controlling the trial
plants from the root up. This strong data validates MustGrow’s
natural science-based approach, utilizing the mustard seed’s
natural defence mechanism, not only as a bio-pesticide, but also as
a bio-herbicide.
MustGrow’s intellectual property suite is a
platform for several crop protection categories, aiming to disrupt
global agriculture markets that have traditionally been dominated
by chemistry-based products. This filing enhances MustGrow’s
current patent portfolio covering many crop protection
categories. MustGrow’s existing patent portfolio protects
both method-of-use and composition-of-matter claims for MustGrow’s
signature mustard-derived approach to controlling unwanted pests,
diseases, and now weeds.
“The efficacious properties of our active
ingredient as a bio-pesticide, bio-nematicide and bio-herbicide
represent a key milestone for MustGrow,” remarked MustGrow COO
Colin Bletsky. “MustGrow has plans to further expand our data
set and focus testing on hard to kill and herbicide-resistant weeds
as well as to expand applications of our remarkable natural
mustard-based technology.”
Global Herbicides Market
According to industry intelligence group
Phillips McDougall, the global herbicides market remained the
dominant crop protection category in 2018, accounting for 42.7% of
crop protection sales – $24.6 billion (+5.9% y/y). This market is
expected to grow by $8.9 billion through 2023 (Source:
Technavio).
The need for bio-herbicides is increasing as
farmers, consumers and regulators seek alternatives to synthetic
chemical pesticides. The dangers associated with synthetic
chemical overuse is pushing these groups to naturally-sourced
bio-herbicides, which are known for safe,
environmentally-sustainable and consumer-friendly profile
characteristics.
About MustGrow
MustGrow is a publicly traded (CSE:
MGRO) (OTC: MGROF) agricultural biotech company focused on
providing natural science-based biological solutions for high value
crops, including fruit & vegetable and cannabis
cultivation. MustGrow has designed and owns a United States
EPA-approved organic solution that uses the mustard seed’s natural
defence mechanism to protect plants from pests and diseases. 110
independent tests have been completed, validating MustGrow’s safe
and effective signature products. This product, in granule format,
is EPA-approved across all key U.S. states as a bio-fertilizer and
bio-pesticide (currently limited to a bio-fertilizer in California)
and is designated by Health Canada’s PMRA (Pest Management
Regulatory Agency) as a fruit & vegetable bio-pesticide and
bio-fertilizer. MustGrow has now concentrated a liquid format to be
applied through standard drip or spray equipment, improving
functionality and performance features.
In cannabis, MustGrow is currently developing
effective, safe and biological solutions that adhere to Health
Canada’s strict regulations, including (1) its mustard-derived
bio-pesticide to treat soil-borne pests and diseases; and (2) an
in-licensed bio-fungicide for powdery mildew.
The Company has approximately 36.2 million basic
common shares issued and outstanding and approximately 54.9 million
on a fully diluted basis. For further details please visit
www.mustgrow.ca.
ON BEHALF OF THE BOARD
"Corey Giasson"
Director & CEO Phone: +1-306-668-2652
Forward-Looking Statements
Certain statements included in this press
release constitute "forward-looking statements" which involve known
and unknown risks, uncertainties and other factors that may affect
the results, performance or achievements of MustGrow.
Generally, forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects", "is expected", "budget", "estimates",
"intends", "anticipates" or "does not anticipate", or "believes",
or variations of such words and phrases or statements that certain
actions, events or results "may", "could", "would", "might",
"occur" or "be achieved".
Forward-looking statements are subject to a
number of risks and uncertainties that may cause the actual results
of MustGrow to differ materially from those discussed in such
forward-looking statements, and even if such actual results are
realized or substantially realized, there can be no assurance that
they will have the expected consequences to, or effects on,
MustGrow.
These risks are described in more detail in
MustGrow’s Prospectus and other continuous disclosure documents
filed by MustGrow with the applicable securities regulatory
authorities and available at www.sedar.com. Readers are
referred to such documents for more detailed information about
MustGrow, which is subject to the qualifications, assumptions and
notes set forth therein.
This release does not constitute an offer for
sale of, nor a solicitation for offers to buy, any securities in
the United States. Neither the CSE nor its Regulation Services
Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this
release.
Important
Always read and follow label use directions. ©
2019 MustGrow Biologics Corp. All rights reserved.
MustGrow Biologics (CSE:MGRO)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
MustGrow Biologics (CSE:MGRO)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024